These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6822498)

  • 41. Functional properties of factor Va subunits after proteolytic alterations by activated protein C.
    Van de Waart P; Bruls H; Hemker HC; Lindhout T
    Biochim Biophys Acta; 1984 May; 799(1):38-44. PubMed ID: 6547061
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neutralization of factor X activity by factor X-specific monoclonal antibodies.
    Ouellette LA; Messier TL; Church WR
    Blood Coagul Fibrinolysis; 1992 Oct; 3(5):563-74. PubMed ID: 1450323
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of phospholipids and factor Va in the prothrombinase complex.
    Rosing J; Tans G; Govers-Riemslag JW; Zwaal RF; Hemker HC
    J Biol Chem; 1980 Jan; 255(1):274-83. PubMed ID: 7350159
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Factor Xa-factor Va complex assembles in two dimensions with unexpectedly high affinity: an experimental and theoretical approach.
    Ye J; Esmon CT
    Biochemistry; 1995 May; 34(19):6448-53. PubMed ID: 7756276
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The activation of bovine protein C by factor Xa.
    Haley PE; Doyle MF; Mann KG
    J Biol Chem; 1989 Sep; 264(27):16303-10. PubMed ID: 2550435
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Monoclonal antibodies selective for the functional states of bovine factor V and factor Va.
    Foster WB; Katzmann JA; Miller RS; Nesheim ME; Mann KG
    Thromb Res; 1982 Dec; 28(5):649-61. PubMed ID: 6891972
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular mechanism of the dysfunction of protein S(Tokushima) (Lys155-->Glu) for the regulation of the blood coagulation system.
    Hayashi T; Nishioka J; Suzuki K
    Biochim Biophys Acta; 1995 Dec; 1272(3):159-67. PubMed ID: 8541347
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The association of coagulation factor Xa and factor Va.
    Pryzdial EL; Mann KG
    J Biol Chem; 1991 May; 266(14):8969-77. PubMed ID: 2026608
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The factor V activation paradox.
    Orfeo T; Brufatto N; Nesheim ME; Xu H; Butenas S; Mann KG
    J Biol Chem; 2004 May; 279(19):19580-91. PubMed ID: 14982929
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interaction of calcium with native and decarboxylated human factor X. Effect of proteolysis in the autolysis loop on catalytic efficiency and factor Va binding.
    Sabharwal AK; Padmanabhan K; Tulinsky A; Mathur A; Gorka J; Bajaj SP
    J Biol Chem; 1997 Aug; 272(35):22037-45. PubMed ID: 9268343
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The factor Xa-catalyzed activation of factor V.
    Foster WB; Nesheim ME; Mann KG
    J Biol Chem; 1983 Nov; 258(22):13970-7. PubMed ID: 6643460
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The catalytic role of anionic phospholipids in the activation of protein C by factor Xa and expression of its anticoagulant function in human plasma.
    Freyssinet JM; Toti-Orfanoudakis F; Ravanat C; Grunebaum L; Gauchy J; Cazenave JP; Wiesel ML
    Blood Coagul Fibrinolysis; 1991 Dec; 2(6):691-8. PubMed ID: 1799656
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Amino acids Glu323, Tyr324, Glu330, and Val331 of factor Va heavy chain are essential for expression of cofactor activity.
    Singh LS; Bukys MA; Beck DO; Kalafatis M
    J Biol Chem; 2003 Jul; 278(30):28335-45. PubMed ID: 12738785
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activation of bovine factor V by an activator purified from the venom of Naja naja oxiana.
    Gerads I; Tans G; Yukelson LYa ; Zwaal RF; Rosing J
    Toxicon; 1992 Sep; 30(9):1065-79. PubMed ID: 1440644
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The interaction of bovine factor V and factor V-derived peptides with phospholipid vesicles.
    Higgins DL; Mann KG
    J Biol Chem; 1983 May; 258(10):6503-8. PubMed ID: 6406482
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Isolation and study of an acquired inhibitor of human coagulation factor V.
    Nesheim ME; Nichols WL; Cole TL; Houston JG; Schenk RB; Mann KG; Bowie EJ
    J Clin Invest; 1986 Feb; 77(2):405-15. PubMed ID: 3944265
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Purification and characterization of a novel protein from bovine aorta that inhibits coagulation. Inhibition of the phospholipid-dependent factor-Xa-catalyzed prothrombin activation, through a high-affinity binding of the anticoagulant to the phospholipids.
    Reutelingsperger CP; Kop JM; Hornstra G; Hemker HC
    Eur J Biochem; 1988 Apr; 173(1):171-8. PubMed ID: 2965640
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
    Camire RM; Kalafatis M; Tracy PB
    Biochemistry; 1998 Aug; 37(34):11896-906. PubMed ID: 9718313
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nematode anticoagulant protein c2 reveals a site on factor Xa that is important for macromolecular substrate binding to human prothrombinase.
    Buddai SK; Toulokhonova L; Bergum PW; Vlasuk GP; Krishnaswamy S
    J Biol Chem; 2002 Jul; 277(29):26689-98. PubMed ID: 12011050
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Construction, expression, and characterization of a chimera of factor IX and factor X. The role of the second epidermal growth factor domain and serine protease domain in factor Va binding.
    Hertzberg MS; Ben-Tal O; Furie B; Furie BC
    J Biol Chem; 1992 Jul; 267(21):14759-66. PubMed ID: 1634519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.